CORMEDIX INC. (CRMD) SEC News April 27, 2026, 12:05 UTC (90% Positive) CORMEDIX INC. (CRMD) Announces Clinical Development Update Full text
Register to leave comments News bot April 27, 2026, 12:05 p.m. 📋 CORMEDIX INC. (CRMD) - Clinical Trial Update Filing Date: 2026-04-27 Accepted: 2026-04-27 08:05:12 Event Type: Clinical Trial Update Event Details: CORMEDIX INC. (CRMD) Announces Clinical Trial Update CORMEDIX INC. (CRMD) provided an update on its clinical development programs. Clinical Development Highlights: Clinical Stage: PHASE III, clinical trialCollaboration: CorMedix Therapeutics 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: CORMEDIX INC.Ticker Symbol: CRMD
📋 CORMEDIX INC. (CRMD) - Clinical Trial Update
Filing Date: 2026-04-27
Accepted: 2026-04-27 08:05:12
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: